PDF Cover

Brain Imaging Devices Market

Brain Imaging Devices Market

The market for Brain Imaging Devices was estimated at $6.4 billion in 2024; it is anticipated to increase to $10.2 billion by 2030, with projections indicating growth to around $15.1 billion by 2035.

Report ID:DS1801028
Author:Debadatta Patel - Senior Consultant
Published Date:October 2025
Datatree
Life Science
Medical Device
Brain Imaging Devices
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Brain Imaging Devices Market Outlook

Revenue, 2024

$6.4B

Forecast, 2034

$13.9B

CAGR, 2024 - 2034

8.14%
The Brain Imaging Devices industry revenue is expected to be around $6.9 billion in 2025 and expected to showcase growth with 8.14% CAGR between 2025 and 2034. The advanced devices have the power to completely transform the way we practice medicine by providing extraordinary insights into the intricate workings of the human brain—the most complex biological structure known to us.

Cutting edge diagnostic tools provide healthcare providers and researchers with visual representations of brain structures and functions to aid in diagnosing and treating neurodegenerative diseases, psychiatric disorders and brain injuries. Recent trends show an increase in their usage driven by advancements in AI and machine learning technologies and the growing incidence of neurological conditions. Brain imaging equipment plays a role not just in diagnosing and treating illnesses but also serves as essential instruments, for neurological and psychological research.

Brain Imaging Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Brain Imaging Devices market is projected to grow from $6.4 billion in 2024 to $13.9 billion in 2034. This represents a CAGR of 8.14%, reflecting rising demand across Clinical Diagnosis, Research and Development and Screening and Monitoring.

  • GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V. are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Brain Imaging Devices market and are expected to observe the growth CAGR of 5.9% to 8.5% between 2024 and 2030.
  • Emerging markets including Brazil, India and China are expected to observe highest growth with CAGR ranging between 7.8% to 10.2%.

  • Transition like Adoption of AI in Brain Imaging is expected to add $1.1 billion to the Brain Imaging Devices market growth by 2030

  • The Brain Imaging Devices market is set to add $7.6 billion between 2024 and 2034, with manufacturer targeting Brain Tumor & Traumatic Brain Injury (TBI) Application projected to gain a larger market share.
  • With Advancements in neurological research, and Rise in neurological disorders, Brain Imaging Devices market to expand 119% between 2024 and 2034.
brain imaging devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Brain Imaging Devices

Brain scanners can play a role in personalized healthcare services with a special focus on neurology by customizing treatment approaches, as per the unique brain scan findings of each patient to enhance treatment effectiveness and drive the need, for cutting edge imaging technology.

Growth Opportunities in North America and Europe

North America Outlook

North America stands out as a center for medical technology in the field of Brain Imaging Devices market with the United States taking the lead position prominently amid a rising elderly population and an uptick in neurological disorders prevalence seen in recent times here. The markets growth is attributed to the presence of established industry leaders and robust research and development undertakings within this region. Strict regulatory standards and substantial healthcare spending play a role in maintaining product quality and ensuring accessibility, to these devices. In todays market environment whichs fiercely competitive for medical equipment and services like PET scans and MRI machines are at the forefront due, to their superior diagnostic capabilities.

Europe Outlook

Europe ranks as the largest market for brain imaging devices thanks to its generous healthcare investment and well established healthcare facilities alongside heightened research endeavors in neurological disorders area. Key market shares are held by nations like Germany France and the UK where prospects lie in creating portable and wireless brain imaging tools, for point of care provisions.

Market Dynamics and Supply Chain

01

Driver: Advancements in Neurological Research, and Evolution of Artificial Intelligence

Recent progress in neuroscience has also sparked an increase in the need for brain imaging tools as researchers seek to gain deeper insights, into brain functions and unravel the mysteries of neurological conditions through innovative imaging methods that offer detailed views of brain functions. The use of Artificial Intelligence in imaging has also brought significant changes to the market, for brain imaging devices. Clever use of AI technology elevates the effectiveness of these devices by enhancing image quality and accuracy while also minimizing errors and aiding in the forecast and prevention of brain related ailments.
With the aging of the worlds inhabitants comes an increase in neurological conditions such as Alzheimers disease and Parkinsons disease as well as stroke cases on the rise too in recent times leading to a surge in demand for precise diagnosis and therapy options thus boosting the requirement, for advanced brain imaging equipment.
02

Restraint: High Cost of Equipment

Brain scanning tools like MRI and CT scans come with a price tag that hinders their widespread use in low and middle income countries due to both the initial purchase cost and ongoing expenses, for maintenance and skilled staff required for operation. This financial obstacle often deters healthcare providers from adopting these technologies. Slows down market expansion.
03

Opportunity: AI-Integrated Imaging and TeleNeuroImaging

The use of Artificial Intelligence in brain imaging tools is a developing trend in the medical field. By leveraging AIs ability to process amounts of data efficiently and accurately the diagnosis of various brain conditions can be made more precise and quicker. This advancement holds the potential to reshape the market, for brain imaging devices significantly.
Access to brain imaging from a distance could revolutionize the way neurological care is provided – in regions without enough specialist resources available for patients in need of such services. TeleNeuroImaging serves as a link connecting patients located far away with neurologists and sets the stage for the expansion of brain imaging technology, within the market.
04

Challenge: Stringent Regulatory Policies

The rules surrounding brain imaging devices are quite intricate and rigorous requiring them to undergo a series of approvals from organizations such as the FDA in the United States and the EMA in Europe before they can be made available for sale, on the market.

Supply Chain Landscape

1
Material Sourcing

General Electric Company

Siemens AG

2
Component Manufacturing

Koninklijke Philips N.V.

Hitachi Ltd

3
Device Assembly

Canon Medical Systems Corporation

Medtronic Plc

4
End User Application and Sales

Hospitals

Diagnostic Imaging Centers

Neurology Centers

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Brain Imaging Devices in Clinical Diagnosis, Research & Development & Screening & Monitoring

Clinical Diagnosis

Brain scanning tools like MRI and CT scanners play a role in the field of medicine for diagnosing brain related issues in clinical settings by identifying any structural irregularities in the brain such as tumors or strokes and allowing prompt treatment interventions to take place when needed. Major industry players such, as GE Healthcare and Siemens Healthineers are known for offering imaging technology that not only provides high quality scans but also prioritizes patient comfort and rapid diagnosis processes.

Research and Development

Brain imaging tools play a role in studying how the brain works and the connections between neural pathways for research purposes. They are essential for neuroscience studies, d research and the creation of new medications. Research pioneers such, as Canon Medical Systems utilize cutting edge technologies to improve efficiency and produce high quality images that boost research progress.

Screening and Monitoring

Hospitals and diagnostic centers are utilizing brain imaging technology frequently to observe and manage patients’ health conditions over time efficiently. This method aids healthcare providers in monitoring disease advancement and treatment efficacy while also examining brain functions and any potential irregularities over a period. Philips Healthcare stands out as a player, in the market offering advanced devices that leverage AI for automated image analysis and enhanced patient monitoring processes.

Recent Developments

March 2024

NeuroCorp has released its cutting edge Neuro 360 device which allows for real time monitoring of brain activity using EEG technology.

June 2024

Brain Dynamics unveiled their groundbreaking brain scanner named BioPlexus that provides detailed imaging with ultra high resolution, through PET and CT technologies.

November 2024

MindTrek Inc introduced the SpectraView. An updated MRI system enhancing resolution and signal strength, for brain imaging.

The Brain Imaging Devices market has seen advancements due to increased efforts in research and development by major companies aiming to create cutting edge technologies for better diagnosis and treatment methods. There is a trend in the market with the fast growth of neuroimaging techniques driven largely by the emergence of hybrid imaging machines, like PET/MRI devices.

Impact of Industry Transitions on the Brain Imaging Devices Market

As a core segment of the Medical Device industry, the Brain Imaging Devices market develops in line with broader industry shifts. Over recent years, transitions such as Adoption of AI in Brain Imaging and Shift Toward Portable Brain Imaging Devices have redefined priorities across the Medical Device sector, influencing how the Brain Imaging Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Adoption of AI in Brain Imaging

The use of Artificial Intelligence is greatly changing the market for brain imaging devices by boosting the efficiency and accuracy of brain scans to improve the specificity and personalization of diagnosis and treatment processes significantly. AI technology can identify brain changes that might go unnoticed, by human clinicians, l which results in earlier and more accurate diagnoses being made. Additionally it is reducing the duration needed for examining brain scans allowing for medical interventions to take place. This industry transition is expected to add $1.1 billion in the industry revenue between 2024 and 2030.
02

Shift Toward Portable Brain Imaging Devices

The arrival of brain imaging gadgets marks another important shift, in this industry sector. They are user friendly devices intended to be brought directly to the patients location – be it a hospital room or an ambulance.

Related Reports

Loading related reports...